Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.17 CHF | +2.13% | +1.56% | +9.78% |
02:00pm | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
05-31 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
Sales 2024 * | 49.08B 44.3B 66.91B | Sales 2025 * | 51.18B 46.19B 69.77B | Capitalization | 210B 190B 287B |
---|---|---|---|---|---|
Net income 2024 * | 10.48B 9.46B 14.29B | Net income 2025 * | 11.74B 10.6B 16.01B | EV / Sales 2024 * | 4.53 x |
Net Debt 2024 * | 12.07B 10.89B 16.45B | Net Debt 2025 * | 10.61B 9.58B 14.47B | EV / Sales 2025 * | 4.32 x |
P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
17.3
x | Employees | 76,057 |
Yield 2024 * |
3.51% | Yield 2025 * |
3.64% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | +2.13% | ||
1 week | +1.56% | ||
1 month | +4.63% | ||
3 months | +3.36% | ||
6 months | +9.12% | ||
Current year | +9.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 17 M€ | +6.09% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 93.17 | +2.13% | 10,828,320 |
24-05-30 | 91.23 | +0.80% | 2,558,199 |
24-05-29 | 90.51 | -0.66% | 2,684,604 |
24-05-28 | 91.11 | -1.00% | 2,322,194 |
24-05-27 | 92.03 | +0.32% | 1,193,903 |
Delayed Quote Swiss Exchange, May 31, 2024 at 11:30 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.78% | 210B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- NOVN Stock